Caira Surgical received $5 million in seed financing.
Caira’s proprietary technology seeks to address the usability, safety and accessibility of advanced surgical navigation and robotics for orthopedic surgery. Its first product is a sub-millimeter-accurate radar tracking system for knee replacement. The system leverages radar technologies to overcome line-of-sight interference and eliminate invasive surgical hardware and high-cost, large footprint capital equipment.
Jon Greenwald, Co-Founder & CEO, said, “The series seed funding enables Caira to continue developing our breakthrough technology and positively impact orthopedic surgery and patient welfare. Additionally, the composition, commitment, and enthusiasm of our investor syndicate ensure that Caira will have continued access to the funding and resources necessary to realize our technology vision and meet our commercial objectives.”
Caira’s previous funding includes a pre-seed Friends & Family financing closed in 2020. In addition, the company received a National Science Foundation Small Business Technology Transfer Grant for $256,000 to research and develop novel radar-based tracking for navigation and robotics in orthopedic surgery.
Caira’s platform technology will expand to address hip and shoulder replacement surgery and spinal applications.
Caira Surgical received $5 million in seed financing.
Caira's proprietary technology seeks to address the usability, safety and accessibility of advanced surgical navigation and robotics for orthopedic surgery. Its first product is a sub-millimeter-accurate radar tracking system for knee replacement. The system leverages radar technologies to...
Caira Surgical received $5 million in seed financing.
Caira’s proprietary technology seeks to address the usability, safety and accessibility of advanced surgical navigation and robotics for orthopedic surgery. Its first product is a sub-millimeter-accurate radar tracking system for knee replacement. The system leverages radar technologies to overcome line-of-sight interference and eliminate invasive surgical hardware and high-cost, large footprint capital equipment.
Jon Greenwald, Co-Founder & CEO, said, “The series seed funding enables Caira to continue developing our breakthrough technology and positively impact orthopedic surgery and patient welfare. Additionally, the composition, commitment, and enthusiasm of our investor syndicate ensure that Caira will have continued access to the funding and resources necessary to realize our technology vision and meet our commercial objectives.”
Caira’s previous funding includes a pre-seed Friends & Family financing closed in 2020. In addition, the company received a National Science Foundation Small Business Technology Transfer Grant for $256,000 to research and develop novel radar-based tracking for navigation and robotics in orthopedic surgery.
Caira’s platform technology will expand to address hip and shoulder replacement surgery and spinal applications.
Copy to clipboard 
